This benefit persisted throughout the four-year study period, suggesting semaglutide does not just help you lose weight but actively protects your cardiovascular system
Although there is a concern for the development of rare pancreatitis, pancreatic cancer or thyroid cancer, a meta-analysis of several databases did not suggest any increased risk of acute pancreatitis or pancreatic cancer with GLP-1RA treatment in T2DM patients [17]
Wegovy is FDA-approved for chronic weight management in adults and pediatric patients aged 12 years and older with obesity (BMI 30 kg/m for adults, 95th percentile for age and sex in pediatrics) or overweight (BMI 27 kg/m for adults, 85th percentile for pediatrics) with at least one weight-related comorbidity
Obesity & Significant Overweight Semaglutide (Wegovy) is FDA-approved specifically for long-term weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related condition
217 In addition, the development of GI dysfunction and motor symptoms following chronic rotenone administration occurs only in conventionally raised mice, but not in GF mice
